The latest clinical guidelines from the American College of Gastroenterology aim to improve the diagnosis and treatment of ...

Long-term budesonide orodispersible tablets effectively maintained remission in patients with eosinophilic esophagitis and demonstrated a favorable safety profile.

Some patients may exhibit clinical features of both gastroesophageal reflux disease (GERD) and EoE and therefore clinical judgment must be used to help decide on the appropriate treatment after ...

Topical steroids taken daily or twice daily do not result in significantly varying outcomes among individuals with eosinophilic esophagitis.

Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops, and markets human healthcare products. The company offers medicines for cardiovascular conditions, diabetes, endocrinology, ...

Equities research analysts at StockNews.com assumed coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Free Report) in a research report issued on Thursday. The brokerage set a “hold” rating on ...

Takeda had hoped that Eohilia would be the first-ever treatment for EoE, but that crown was snatched by Sanofi and Regeneron’s injectable antibody Dupixent (dupilumab), which was approved for ...

StockNews.com assumed coverage on shares of DBV Technologies (NASDAQ:DBVT – Free Report) in a research note published on Thursday morning. The firm issued a hold rating on the stock. Several other ...

Esophageal dilation is a treatment to help stretch, or dilate, abnormal narrowings found in the esophagus. These narrowings are called strictures and can occur from a variety of health problems. They ...

Compared with female patients, male patients with eosinophilic esophagitis have higher rates of complications, including ...

Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...